Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
$25.61+0.20%Close
SELLBULL · day 457
Key stats
- Market cap
- $1.4B
- Beta
- 0.14
- P/E (TTM)
- -25.87
- 1W
- -0.16%
- 1M
- -0.08%
- vs SPY 1W
- -0.58%
- vs SPY 1M
- -2.14%
Industry peers
FMP comparable companies · ranked by market cap
- BKDSELLBrookdale Senior Living Inc.$2.4BCRISISQ 5$10.24+1.19%
- NXGNNextGen Healthcare, Inc.$1.6B$23.94
- AGTIAgiliti, Inc.$1.4B$10.05
- PNTPOINT Biopharma Global Inc.$1.3B$12.50
- HSKAHeska Corporation$1.3B$119.99
- CINCCinCor Pharma, Inc.$1.3B$29.06
- CTICCTI BioPharma Corp.$1.2B$9.10
- SILKSilk Road Medical, Inc$1.1B$27.49
- FNAParagon 28, Inc.$1.1B$13.09
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on HROWL?
- LOPJLB’s latest quantitative signal on Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) is SELL in a BULL regime. Signals are updated daily.
- What market regime is HROWL in?
- Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) do?
- Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and …